CXCL8 and cancer: Our hypothesis assumes that the anti-cancer effect of isorhamnetin is related to its ability to interfere with the biosynthesis of interleukin 8, which is a cytokine released from cancer cells that regulates the processes of proliferation, angiogenesis and migration of cancer cells, and is related to the potential of isorhamnetin to affect the oxidative status of cancer cells as well.